Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variability of glutathione S-transferases influences treatment outcome of breast cancer.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Aug 2015

Zhou Liang, Huang Anzhong, Zhang Dawei, Yao Junliang, Zhang Yong, Li Xuejiao

Abstract excerpt

We investigated the relationship between the clinical outcome and the GSTM1 null/present, GSTT1 null/present, and GSTP1 IIe105Val polymorphisms in breast cancer patients with chemotherapy. A total of 420 consecutive breast cancer patients diagnosed between January 2010 and December 2011 were eligible for inclusion in our retrospective study. The designs of the assay and SNP genotyping of GSTM1 null/present, GSTT1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Glutathione S-Transferase pi

Share to Glutathione Transferase

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Share to Treatment Outcome

Source

Identifiers

PMID: 25773389
DOI: 10.1007/s13277-015-3266-9

Genes

GSTP1
GSTM1
GSTT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variability of glutathione S-transferases influences treatment outcome of breast cancer.PMID 25773389Read ↗

Glutathione S-transferase polymorphisms influence chemotherapy response and treatment outcome in breast cancer.Semantic proximity Read ↗

Predictive potential role of glutathione S-transferases polymorphisms in response to chemotherapy and breast cancer prognosis.Semantic proximity Read ↗

Predictive potential role of glutathione S-transferase polymorphisms in the prognosis of breast cancer.Semantic proximity Read ↗

Predictive assessment in pharmacogenetics of Glutathione S-transferases genes on efficacy of platinum-based chemotherapy in non-small cell lung cancer patients.Semantic proximity Read ↗

Polymorphisms in GSTT1 and GSTM1 genes as possible risk factors for susceptibility to breast cancer development and their influence in chemotherapy response: a systematic review.Semantic proximity Read ↗

GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.Semantic proximity Read ↗

Association of GSTs gene polymorphisms with treatment outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.Semantic proximity Read ↗

Predictive role of GSTs on the prognosis of breast cancer patients with neoadjuvant chemotherapy.Semantic proximity Read ↗

Pharmacogenetic influence of GST polymorphisms on anthracycline-based chemotherapy responses and toxicity in breast cancer patients: a multi-analytical approach.Semantic proximity Read ↗

GSTT1 and GSTM1 polymorphisms predict treatment outcome for breast cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Predictive role of Glutathione S-transferases (GSTs) on the prognosis of osteosarcoma patients treated with chemotherapySemantic proximity Read ↗

The GSTP1 105Val allele increases breast cancer risk and aggressiveness but enhances response to cyclophosphamide chemotherapy in North China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.